CD19-Positive Neoplastic Cells Present

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB09052Blinatumomab1Recruiting1
DB06186Ipilimumab1Recruiting1
DB00075Muromonab1Recruiting1
DB09035Nivolumab1Recruiting1